Amundi Pliant Therapeutics, Inc. Transaction History

Amundi

$275 Billion
Q1 2025

A detailed history of Amundi transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Amundi holds 138 shares of PLRX stock, worth $187. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138

Previous 52 165.38%

Holding current value

$187

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 15, 2025	BUY	$1.35 - $13.53 $116 - $1,163	86 Added 165.38%	138 $0
Q4 2024 Feb 07, 2025	BUY	$10.55 - $15.7 $548 - $816	52 New	52 $0

Others Institutions Holding PLRX

# of Institutions

154

Shares Held

62.2M

Call Options Held

279K

Put Options Held

7.1K

Tang Capital Management LLC San Diego, CA

6M
Shares

$8.16 Million
0.53% of portfolio
Deep Track Capital, LP Greenwich, CT

5.4M
Shares

$7.34 Million
0.25% of portfolio
Black Rock Inc. New York, NY

4.97M
Shares

$6.76 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.33M
Shares

$4.54 Million
0.0% of portfolio
Morgan Stanley New York, NY

3.05M
Shares

$4.15 Million
0.0% of portfolio

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $66.2M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account